Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.

NCT03077165 is registered in ClinicalTrials.gov with Ilkos Therapeutic Inc. as lead sponsor.

NCT NCT03077165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 10-week Randomized, Double-blind, Placebo-controlled, Prospective, International, Multicentre, Phase IIa Study of S42909 on Leg Ulcer Healing.
Lead sponsor
Ilkos Therapeutic Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 12, 2017
Completion date
January 22, 2020
Enrollment
121 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer